Design, Write, and Execute Clinical Trials in Interventional Oncology
The Interventional Oncology Clinical Trials Methodology Workshop (IOCTMW) is an intensive, five-day educational program designed to equip interventional oncologists with the foundational and advanced skills necessary to design, write, and execute clinical trials. Held in an intimate setting at Penn Medicine, the program will foster collaboration and mentorship by blending didactic sessions, protocol development groups (PDGs), and one-on-one learning to address the unique challenges and opportunities in IO research.
Dates: 19-23 May 2026
Location: University of Pennsylvania, The Study at University City
Submit Your Application
About the Workshop:
Participants will explore trial design across all phases, regulatory frameworks, statistical principles, and emerging methodologies including AI, cost-effectiveness analysis, and pragmatic trials. Special emphasis is placed on integrating biomarkers, imaging, and real-world data into trial design, as well as navigating multi-center collaborations and funding strategies.
This program is ideal for early- to mid-career interventional oncologists, physician-scientists, and clinical researchers seeking to elevate their research impact and contribute meaningfully to the advancement of evidence-based IO practice.
Scholarship Award:
Seats are limited for this unique educational experience. Applicants will undergo a rigorous selection process conducted by the course directors.
Invited participants will receive:
- Complimentary Interventional Oncology Clinical Trials Methodology Workshop (IOCTMW) registration
- Complimentary five-night stay at The Study at University City
- $750 travel stipend
Key Dates:
Application Opens: Thursday, 23 October 2025
Application Closes: Friday, 16 January 2026 at 11:59 p.m. ET
Notifications Issued: Monday, 16 February 2026
Course Date: 19-23 May 2026
Learning Objectives:
By the end of the workshop, participants will be able to:
- Design a clinical trial protocol tailored to interventional oncology, including objectives, endpoints, and statistical considerations.
- Navigate regulatory requirements including FDA device regulation, informed consent, and Good Clinical Practice (GCP).
- Apply statistical concepts such as hypothesis testing, sample size calculation, and regression modeling to clinical trial design.
- Integrate correlative studies including imaging and biomarker analysis into trial methodology.
- Evaluate and incorporate real-world data from registries and electronic health records into observational study designs.
- Develop strategies for trial funding, budgeting, and industry collaboration.
- Address barriers to patient accrual and implement solutions to improve recruitment and retention.
- Collaborate effectively with statisticians and build multidisciplinary research teams.
- Understand the nuances of multicenter trial operations, including site selection, startup, and coordination.
- Critically assess and incorporate patient-centered outcomes such as quality of life, financial toxicity, and healthcare utilization.
The Interventional Oncology Clinical Trials Methodology Workshop (IOCTMW) is supported by educational grants from AstraZeneca and Johnson & Johnson